A preclinical orthotopic model for glioblastoma recapitulates key features of human tumors and demonstrates sensitivity to a combination of MEK and PI3K pathway inhibitors

Current therapies for glioblastoma multiforme (GBM), the highest grade malignant brain tumor, are mostly ineffective, and better preclinical model systems are needed to increase the successful translation of drug discovery efforts into the clinic. Previous work describes a genetically engineered mou...

Descripción completa

Detalles Bibliográficos
Autores principales: El Meskini, Rajaa, Iacovelli, Anthony J., Kulaga, Alan, Gumprecht, Michelle, Martin, Philip L., Baran, Maureen, Householder, Deborah B., Van Dyke, Terry, Weaver Ohler, Zoë
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Company of Biologists Limited 2015
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4283649/
https://www.ncbi.nlm.nih.gov/pubmed/25431423
http://dx.doi.org/10.1242/dmm.018168

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4283649/
https://www.ncbi.nlm.nih.gov/pubmed/25431423
http://dx.doi.org/10.1242/dmm.018168

Ejemplares similares